BOSTON, MA--(Marketwire - December 08, 2010) -
Highlighted Links |
|
Spencer Pharmaceutical Inc. (PINKSHEETS: SPPH) announced today the dinner scheduled for today is confirmed. The event honouring Al-Dorra originally scheduled for Tuesday, November 30th was rescheduled to Wednesday, December 8th. This is a confirmation that the dinner in honour of Al-Dorra is going ahead as originally announced last week at the Mount Stephan Club in Montreal, Canada.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.
Important Information About Forward-Looking Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company’s website does not constitute a part of this release.
Contact:
Dr. Max Arella
President
Spencer Pharmaceutical Inc.
Tel. 1+(617) 973-5017